Firefly Neuroscience AIFF
NASDAQ AIFF
$1.13 +0.03 (+2.73%)
At close: Sep 4, 2026 · 4:00 PM EDT

Firefly Neuroscience (AIFF) Divestments (2023)

Firefly Neuroscience (AIFF) posted Divestments of $935974.0 for Q1 2023.

Analysis

Firefly Neuroscience (AIFF) Divestments (2023) Analysis & Trends

Firefly Neuroscience has reported Divestments for 1 years, with the latest figure at $935974.0 in Q1 2023.

  • On a quarterly basis, Divestments changed N/A year-over-year to $935974.0 in Q1 2023; TTM through Dec 2023 was $935974.0, a N/A change from a year earlier, with the FY2023 full-year figure at $935974.0, changed N/A from the prior year.
  • Divestments was $935974.0 for Q1 2023 at Firefly Neuroscience.
  • The five-year high for Divestments was $935974.0 in Q1 2023, with the low at $935974.0 in Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn -
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn -
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn -
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn -
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn -
6 QuidelOrtho 954.15 Mn 830.75 Mn - -
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn -
8 Anbio Biotechnology 941.05 Mn 929.15 Mn - -
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn -
10 Firefly Neuroscience 23.25 Mn 14.03 Mn 253,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 935,974.00